Ipswich Investment Management Co., Inc. Crispr Therapeutics Ag Transaction History
Ipswich Investment Management Co., Inc.
- $403 Million
- Q4 2024
A detailed history of Ipswich Investment Management Co., Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ipswich Investment Management Co., Inc. holds 25,288 shares of CRSP stock, worth $1.04 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
25,288
Previous 24,538
3.06%
Holding current value
$1.04 Million
Previous $1.15 Million
13.7%
% of portfolio
0.25%
Previous 0.28%
Shares
28 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$369 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$360 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$157 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$114 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$113 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.21B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....